UNSPSC 51111729: Arsenic trioxide

This classification denotes a differentiation inducer, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S7V92P67HO. European Medicines Agency schedules Arsenic trioxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12467MIG. Arsenic trioxide generally arises in the molecular formula AS2O3. The term ARSENIC TRIOXIDE is a United States Adopted Name designation. Most nations schedule arsenic trioxide under HS 28112990 and SITC 52239.

As of Q4 2014, ARSENIC TRIOXIDE remains the US FDA Preferred Term for this commodity. Arsenic trioxide bears US NLM identifiers UMLS ID C0052416 and NCI Concept Code C1005. SMILES: O1[As]2O[As]1O2.

UNSPSC 51111729 Arsenic trioxide is a Commodity code that captures pharmaceutical and chemical supply procurement by state and local health agencies, though recent state and local activity under this code shows limited direct relevance to the nominal product — the opportunities tagged to it reflect broader pharmaceutical warehouse and public health supply sourcing rather than arsenic trioxide specifically. State and local buyers posting under this code include health departments, county public health authorities, and specialized health procurement consortia. The scope of work encompasses pharmaceutical supply agreements, often structured as piggyback or cooperative purchasing contracts through multi-agency consortia such as MMCAP, with quarterly or as-needed delivery schedules to health facilities and community health buildings.

Geographic activity centers on Illinois and Florida based on recent opportunities. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026 through the MMCAP Infuse consortium (Bid 26-482DPH-PREPD-B-53392, IFB, closed award) for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets with a 12-month initial term and renewal options through year 3. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023, now closed) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, including potential FEMA funding and associated federal compliance requirements. Neither opportunity directly reflects arsenic trioxide procurement; the code appears to capture pharmaceutical sourcing more broadly rather than this specific commodity.